Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes

Journal of Neurophysiology

Volumn 114, Issue 1, 2015, Pages 199-208

  Shevalye, Hanna ^b   Yorek, Matthew S ^a,c   Coppey, Lawrence J ^b   Holmes, Amey ^a   Harper, Matthew M ^a,b,c   Kardon, Randy H ^a,b,c   Yorek, Mark A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VA Center of Excellence for Prevention and Treatment of Visual Loss   (United States)

Author keywords

Corneal nerve fibers; Diabetic neuropathy; Epidermal nerve fibers; Fish oil; Resolvin; Type 2 diabetes

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; FATTY ACID; HEMOGLOBIN A1C; ICOSANOID; MENHADEN OIL; OMEGA 3 FATTY ACID; PROTEASOME; RESOLVIN D1; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; FISH OIL; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORNEA; DIABETIC NEUROPATHY; DIET; DIET THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HYPERGLYCEMIA; INNERVATION; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID DIET; MOTOR NERVE CONDUCTION; MOUSE; NERVE CONDUCTION; NERVE FIBER GROWTH; NEUROPROTECTION; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIMARY CULTURE; PRIORITY JOURNAL; RETINA GANGLION CELL; SENSORY NERVE; SENSORY NERVE CONDUCTION; SKIN; SPINAL GANGLION; STEATOSIS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; C57BL MOUSE; CELL CULTURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENT; DRUG EFFECTS; HEAT; HYPERALGESIA; NERVE CELL; NEURITE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CORNEA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FISH OILS; GANGLIA, SPINAL; HOT TEMPERATURE; HYPERALGESIA; MICE, INBRED C57BL; NEURAL CONDUCTION; NEURITES; NEURONS; NEUROPROTECTIVE AGENTS; RETINAL GANGLION CELLS; SKIN;

EID: 84937006559     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00224.2015     Document Type: Article

References (53)

1. Agrawal NK, Kant S. Targeting inflammation in diabetes: newer therapeutic options. World J Diabetes 5: 697-710, 2014.
2. Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 102: 10858-10863, 2005.
3. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 28: 176-183, 2007.
4. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 102: 7671- 7676, 2005.
5. Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link? Mol Cell Endocrinol. First published February 24, 2015; doi:10.1016/j.mce.2015.02.018.
6. Bazan NG. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res 50: S400-S405, 2009.
7. Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's and other neurodegenerative diseases. Annu Rev Nutr 31: 321-351, 2011.
8. Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol 187: 1957-1969, 2011.
9. Chen J, Shetty S, Zhang P, Gao R, Hu Y, Wang S, Li Z, Fu J. Aspirintriggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. Toxicol Appl Pharmacol 277: 118-123, 2014.
10. Claria J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol 189: 2597-2605, 2012.
11. Coppey L, Davidson E, Lu B, Gerard C, Yorek M. Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice. Neuropharmacology 60: 259-266, 2011.
12. Coppey LJ, Davidson EP, Obrosov A, Yorek MA. Enriching the diet with menhaden oil improves peripheral neuropathy in streptozotocin-induced type 1 diabetic rats. J Neurophysiol 113: 701-708, 2015.
13. Coppey LJ, Holmes A, Davidson EP, Yorek MA. Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat. J Nutr Metab 2012: 950517, 2012.
14. Cortina MS, He J, Li N, Bazan NG, Bazan HE. Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest Ophthalmol Vis Sci 51: 804-810, 2010.
15. Davidson E, Coppey L, Holmes A, Yorek M. Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat. Invest Ophthalmol Vis Sci 53: 1182-1187, 2012a.
16. Davidson EP, Coppey LJ, Kardon RH, Yorek MA. Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats. Invest Ophthalmol Vis Sci 55: 1222-1230, 2014.
17. Davidson EP, Coppey LJ, Yorek MA. Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment. Invest Ophthalmol Vis Sci 53: 8067-8074, 2012b.
18. Efron N. Assessing diabetic neuropathy using corneal confocal microscopy. Invest Ophthalmol Vis Sci 53: 8075, 2012.
19. Figueras M, Olivan M, Busquets S, Lopez-Soriano FJ, Argiles JM. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity (Silver Spring) 19: 362-369, 2011.
20. Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran- Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins. FASEB J 23: 1946-1957, 2009.
21. Gordon WC, Bazan NG. Mediator lipidomics in ophthalmology: targets for modulation in inflammation, neuroprotection and nerve regeneration. Curr Eye Res 38: 995-1005, 2013.
22. Hellmann J, Tang Y, Kosuri M, Bhatnagar A, Spite M. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J 25: 2399-2407, 2011.
23. Jelinek D, Castillo JJ, Arora SL, Richardson LM, Garver WS. A high-fat diet supplemented with fish oil improves metabolic features associated with type 2 diabetes. Nutrition 29: 1159-1165, 2013.
24. Katakura M, Hashimoto M, Inoue T, Al Mamun A, Tanabe Y, Iwamoto R, Tsuchikura S, Shido O. Omega-3 fatty acids protect renal functions by increasing docosahexaenoic acid-derived metabolite levels in SHR. Cg- Leprcp/NDmcr rats, a metabolic syndrome model. Molecules 19: 3247- 3263, 2014.
25. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 158: 960-971, 2009.
26. Lamping KG, Nuno DW, Coppey LJ, Holmes AJ, Hu S, Oltman CL, Norris AW, Yorek MA. Modification of high saturated fat diet with n-3 polyunsaturated fat improves glucose intolerance and vascular dysfunction. Diabetes Obes Metab 15: 144-152, 2013.
27. Lee CH. Resolvins as new fascinating drug candidates for inflammatory diseases. Arch Pharm Res 35: 3-7, 2012.
28. Malik RA. Early detection of nerve damage and repair in diabetic neuropathy. Nat Clin Pract Neurol 4: 646-647, 2008.
29. Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, Efron N, Boulton AJ. Corneal confocal microscopy: a noninvasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 46: 683-688, 2003.
30. Malin SA, Davis BM, Molliver DC. Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity. Nat Protoc 2: 152-160, 2007.
31. Mas E, Croft KD, Zahra P, Barden A, Mori TA. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 58: 1476-1484, 2012.
32. Mehra S, Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, Augustine T, Malik RA. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 30: 2608-2612, 2007.
33. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58: 2047-2067, 2011.
34. Norling LV, Perretti M. The role of omega-3 derived resolvins in arthritis. Curr Opin Pharmacol 13: 476-481, 2013.
35. Otoda T, Takamura T, Misu H, Ota T, Murata S, Hayashi H, Takayama H, Kikuchi A, Kanamori T, Shima KR, Lan F, Takeda T, Kurita S, Ishikura K, Kita Y, Iwayama K, Kato K, Uno M, Takeshita Y, Yamamoto M, Tokuyama K, Iseki S, Tanaka K, Kaneko S. Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in liver. Diabetes 62: 811-824, 2013.
36. Palacios-Pelaez R, Lukiw WJ, Bazan NG. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol 41: 367-374, 2010.
37. Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, Finnigan J, Marshall A, Boulton AJ, Efron N, Malik RA. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56: 2148-2154, 2007.
38. Robson LG, Dyall S, Sidloff D, Michael-Titus AT. Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurons throughout development and in aged animals. Neurobiol Aging 31: 678- 687, 2010.
39. Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, Pfeffer MA, Priluck R, Serhan CN, Levy BD. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol 189: 1983-1991, 2012.
40. Sandireddy R, Yerra VG, Areti A, Komirishetty P, Kumar A. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol 2014: 674987, 2014.
41. Sarbolouki S, Javanbakht MH, Derakhshanian H, Hosseinzadeh P, Zareei M, Hashemi SB, Dorosty AR, Eshraghian MR, Djalali M. Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: a double-blind randomized clinical trial. Singapore Med J 54: 387-390, 2013.
42. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 1025-1037, 2002.
43. Shaikh SR, Kinnun JJ, Leng X, Williams JA, Wassall SR. How polyunsaturated fatty acids modify molecular organizations in membranes: insight from NMR studies of model systems. Biochim Biophys Acta 1848: 211-219, 2015.
44. Singh B, Xu Y, McLaughlin T, Singh V, Martinez JA, Krishnan A, Zochodne DW. Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem 121: 263-276, 2012.
45. Spite M, Claria J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 19: 21-36, 2014.
46. Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res 26: 1015-1035, 1985.
47. Tavakoli M, Kallinikos P, Iqbal A, Herbert A, Fadavi H, Efron N, Boulton AJ, Malik RA. Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet Med 28: 1261-1267, 2011.
48. Tavakoli M, Quattrini C, Abbott C, Kallinikos P, Marshall A, Finnigan J, Morgan P, Efron N, Boulton AJ, Malik RA. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 33: 1792-1797, 2010.
49. Titos E, Claria J. Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation. Prostaglandins Other Lipid Mediat 107: 77- 84, 2013.
50. Yorek MS, Obrosov A, Shevalye H, Lupachyk S, Harper MM, Kardon RH, Yorek MA. Effect of glycemic control on corneal nerves and peripheral neuropathy in streptozotocin-induced diabetic C57Bl/6J mice. J Peripher Nerv Syst 19: 205-217, 2014.
51. Yorek MA, Bohnker RR, Dudley DT, Spector AA. Comparative utilization of n-3 polyunsaturated fatty acids by cultured human Y-79 retinoblastoma cells. Biochim Biophys Acta 795: 277-285, 1984.
52. Yorek MS, Obrosov A, Shevalye H, Holmes A, Harper MM, Kardon RH, Yorek MA. Effect of diet induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J mice. J Peripher Nerv Syst. First published April 10, 2015; doi:10.1111/jns.12111.
53. Zhou J, Zhou S. Inflammation: therapeutic targets for diabetic neuropathy. Mol Neurobiol 49: 536-546, 2014.